One-day-old ducklings experimentally infected with duck hepatitis B virus (DHBV) were found to be immunologicaUy tolerant to virus antigens (DHBsAg, DHBcAg), with no humoral or cellular immune responses being detected. When immunized with virus antigens in Freund's complete adjuvant, no immune responses could be induced. Rabbit anti-DHBs sera were complexed to a solid matrix (Staphylococcus aureus Cowan A strain) and purified DHBsAg was bound to this complex to form a solid matrix antibody-antigen (SMAA) complex. This SMAA was used as an immunogen to immunize the tolerant ducks. After three injections, in 12 of 17 ducks serum DHBV DNA became absent and serum DHBsAg was cleared. In eight of 16 ducks, low titres of anti-DHBs could be detected. The SMAA approach shows potential for application in immunoregulatory treatment for chronically infected hepatitis B patients.
Introduction
Duck hepatitis B virus (DHBV) belongs to the newly characterized Hepadnaviridae family, with human hepatitis B virus (HBV) being the prototype (Gust et al., 1986) . The most common natural mode of transmission for HBV is via perinatal exposure of infants to carrier mothers, and there is a correlation between exposure to HBV at an early age and a high incidence of chronic HBV carriage (Beasley & Hwang, 1984) . Progression to chronic HBV infection is characterized by persistence of subviral surface antigen particles (HBsAg) in serum, with no detectable anti-HBs. Immune tolerance to the envelope protein of HBV could be one of the factors involved in the development of the carrier state. In the duck system, natural transmission is predominantly from mother to egg; however, experimental injection of DHBV into newly hatched ducklings can also result in chronic infection. In some breeds of ducklings, DHBV viraemia and antigenaemia can persist for months or years, which simulates the symptoms of perinatal HBV infection, and these chronic antigenaemic carriers rarely clear the virus.
An immunogen, termed solid matri~antibody-antigen (SMAA) complex, has been described, which was constructed using 'fixed' and killed suspensions of the Cowan A strain of Staphylococcus aureus as the solid matrix, a monoclonal antibody raised against individual simian virus 5 (SV5) structural proteins comptexed to the matrix and subsequently SV5 viral antigens were attached. When SMAA was used to immunize mice, humoral and cytotoxic T cell responses to the structural proteins of SV5 were induced . Immunization with SMAA (anti-SVS) reduced the amount of virus replication within a mouse model, and a protective immune response in infected mice was observed .
To study an approach towards inducing an immune response in HBV chronic carriers that would help to control the infection, we have constructed a SMAA complex using S. aureus Cowan A strain, polyclonal anti-DHBs as the antibody and DHBsAg as the antigen to immunize persistently infected ducks. In some ducks DHBV DNA became undetectable in assocation with clearance of antigenaemia and appearance of anti-DHBs. This approach seems promising and could provide a model for a new and more effective immunoregulatory treatment for chronic HBV carriers.
Methods
Animals. Fu Rong ducks (a hybrid of Pekin duck and Cherry Valley duck) were used. The natural infection rate of DHBV in this breed is low (2 to 5 %), and persistence of DHBV after experimental infection during the first week of age can last as long as 2 years (data not shown).
Infection with DHBV. One-day-old ducklings were inoculated intraperitoneally with 100 p.l of DHBV DNA-positive serum (estimated 7.8 x 108 copies/ml). The amount of DHBV was calculated by dot-blot DNA hybridization, as compared with serial dilutions of cloned DHBV DNA (Qu et al., 1988) . Infected ducklings were bled every 2 weeks to test for serum DHBV DNA and DHBsAg for up to 8 weeks. Only those ducklings which were persistently infected were used for SMAA studies. The infection rates were 94 to 100 % in separate experiments and 75 to 80% of ducklings remained serum DHBV DNA-and DHBsAg-positive. All 1-day-old ducklings were bled prior to experimental infection and checked for serum DHBsAg and DHBV DNA. Those infected in ovo were kept separately.
Detection of serum DHBV surface antigen (DHBsAg) . As reported previously (Zhang et al., 19881) , a dot-enzyme imrnunoassay test was used for the detection of DHBs antigenaemia. Ten microlitre serum samples were spotted onto nitrocellulose filter sheets and dried overnight at 4 °C. After washing with PBS and blocking with 30 % calf serum, rabbit anti-DHBs (prepared in this laboratory and absorbed with normal duck serum) was used to react with the membrane for 2 h. Bound antibody was detecter~ with peroxidase-labelled S. aureus Protein A and 4-chloro-l-naphthol was used as the substrate. DHBsAg (anti-DHBs) and DHBcAg (anti-DHBc) . A sandwich ELISA was used for the detection of antiDHBs and anti-DHBc in ducks. DHBsAg particles were purified from DHBV naturally infected duck serum (Marion et al., 1983) , and their purity was determined by electron microscopy and SDS-PAGE. Purified DHBsAg was used to coat wells in 96-well polystyrene plates, and serial dilutions of duck sera were inoculated in duplicate and added to the wells. Bound anti-DHBs was detected by peroxidase-labelled rabbit anti-duck Ig, using o-phenylenediamine as the substrate, measured as A49 U. From the A values a reading > 21 the background value was considered positive. For detection of anti-DHBc, core particles were purified from the livers of naturally infected ducks (Hu et al., 1992) and used for coating the wells. The ELISA was the same as that used for detecting anti-DHBs. Sera from normal adult ducks immunized with DHBsAg or DHBcAg (prepared in this laboratory) were used as positive controls. When sera were tested for evaluation of SMAA immunization, samples collected prior to and after all immunizations were tested simultaneously for comparison.
Deteetion of antibodies against
Specific lymphocyte proliferation test for DHBsAg and DHBcAg. As described previously (Zfiang et al., 1990) , the duck lymphocyte proliferative response to stimulation by phytohaemagglutinin IPHA) was fully developed at 8 weeks of age, and this was taken as the age at which cell-mediated immune responses (CMI) are mature in ducks. The method employed was a modification of that of Higgins & Tech (1988) . Peripheral blood samples from ducks were heparinized and, after dilution with Hanks' solution, carefully layered over Ficoll-Hypaque solution (specific gravity 1.077 _+ 0-002) in glass tubes. The tubes were centrifuged at 1100 r.p.m, for 25 rain at 20 °C. Cells at the interface were collected and washed with PBS and subsequently with RPMI 1640. Cells were adjusted to 2x 106/ml, and 100 gl cell suspension was dispensed in each well. Prior to this study, peripheral blood mononucleocytes from ducks immunized with DHBsAg or DHBcAg were tested and the antigen concentration for stimulation was 50 ~tg/ml for each. (data not shown). For the detection of CMI in infected ducks, 5 gg of either DHBsAg or DHBcAg was added to each well and cultures were incubated at 41-3 °C for 96 h. Radiolabelling was achieved by adding 10gl of RPMI containing 0.5 gCi of [~H] thymidine to each well. Cells were harvested onto glass fibre nets using a semi-automated harvester, and, after they had been washed, individual discs of each culture were counted. The stimulation index (SI) was calculated using the mean counts per minute of triple cultures over the unstimulated control cultures.
Detection of serum DHBV DNA. As reported previously (Li et al., 1989) , 20 gl of duck sera was filtered onto a nitrocellulose filter using a 96-well manifold apparatus. Filters were alkali-denatured, neutralized, baked and hybridized with an [e-3~P]dCTP-labelled cloned DHBV DNA probe. After washing, the filters were subjected to autoradiography.
Production of SMAA complexes and #nmunization of ducks. The method for the formation of SMAA complexes was based on that described by . Cowan A strain S. aureus was grown on agar plates and 0.4 % formaldehyde was added (10 % w/v) to make a bacterial suspension, which was kept at 4 °C overnight. After washing with 0.01 M-PBS pH 7.2, an equal volume of rabbit anti-DHBs (ELISA titre 1:50000) was incubated with the bacteria at 4 °C overnight on a shaker to allow the adsorption of the antibody Fc fragment to the Protein A on the bacterial surface. Unbound antibody was removed by centrifugation (3000 r.p.m, for 15 min) of the solid matrix-antibody (SMA) complexes three times in PBS. After the final wash, the complex was resuspended at the original volume. An equal volume of purified DHBsAg (protein concentration 600 gg/ml) was then mixed continuously with the SMA complex at 4 °C overnight. The resulting SMAA complex was first washed with immunoprecipitation buffer (20 mM-Tris HC1 pH 7.2, 5 mM-EDTA, 0'5% NP40, 0.01% SDS and 0.65 M-NaCt), and then washed twice in PBS. The SMAA complex was divided into samples and frozen at -70 °C. SMAA complex was mixed with Freund's complete adjuvant and injected subcutaneously at three or four sites on the back of tolerant ducks. The amount of injected SMAA was equivalent to 3 to 6 pg of DHBsAg for each duck per injection. Three injections were given in total, at 3 week intervals. Ducks were bled 3 weeks after each injection and serum DHBsAg, DHBV DNA and anti-DHBs were assayed. S. aureus suspension (SM), anti-DHBs complexed to SM (SMAb), SM combined with DHBsAg (SMAg) or only Frennd's complete adjuvant were used separately to inject tolerant ducks and these served as control groups.
Results

Immune responses in ducks infected when 1 day old
Ducklings infected at day 1 that then became persistently positive for DHBV DNA and DHBsAg for 8 weeks were assayed for their anti-DHBs and anti-DHBc. Using the ELISA we have described, no anti-DHBs or anti-DHBc was detected 8 weeks after infection. SI values against DHBsAg or DHBcAg were less than 2.1, indicating that these ducks were immunologically tolerant to DHBV antigens. To study whether immune responses in ducks could be induced by repeated stimulation with DHBV antigens, two immune tolerant ducks were immunized with purified DHBsAg (100 lag/duck), and another two were immunized with purified DHBcAg (100 tag/duck) with Freund's complete adjuvant five times at 3 week intervals. Two non-infected adult ducks from the same batch of animals were immunized with the same antigens using the protocol above. As shown in Table 1 , immunized normal ducks developed humoral and cellular immune responses against DHBsAg and DHBcAg, whereas no such immune responses were observed in the infected tolerant ducks.
Seroconversion of DHBV DNA and DHBsAg with SMAA
In total, 33 tolerant ducks were studied in three separate experiments. Among these, 17 tolerant ducks were immunized with SMAA, and another 16 were immunized with either SM, SMAb or SMAg or only with Freund's complete adjuvant, using the same protocol as that used for the control groups. Results are shown in Tables 2 and  3 .
Duration of anti-DHBs in serum of SMAA-immunized ducks
Four DHBV-immune and -tolerant ducks that seroconverted to become anti-DHBs-positive were followed after the third injection. Three of four ducks were still antiDHBs-positive 5 weeks after the final injection. To study whether these ducks could be boosted with DHBsAg alone, they were injected with purified DHBsAg and then the resultant antibodies were tested. Although antiDHBs could be detected after boosting, no significant increase in antibody titres was observed,
Discussion
Transplacental and perinatal viral infections can lead to immunological tolerance. Although failure in T cell immunity is more common, exposure to the virus in utero does not always cause a permanent deletion of specific T cells, since T cell unresponsiveness is reversible (Jamieson & Ahmad, 1988) . In hepadnavirus infections, ducks congenitally infected with DHBV are similar to patients transplacentally infected with HBV, whereas ducklings infected at 1 day old are comparable with perinatal HBV-infected infants. In chronic HBV infections, antibodies raised against the core antigen (HBcAg) are usually present in high titres, but cytotoxic T cells raised (Penna et al., 1991) . Antibody raised against the surface antigen, which is protective (anti-HBs), is usually not detectable. Although in some patients antiHBs has been detected by dissociation of the immune complex or by specific sensitive assays (Maruyama et al., 1992) , the persistent presence of the antigen indicates there is a certain degree of immune tolerance.
In the present study, we have investigated both humoral and cellular immune responses in persistently DHBV-infected ducks. In contrast to human infections with HBV, anti-DHBc was not detected. Since it was found that anti-DHBc could be detected at only a very low titre in some infected ducks during a short period (Halpern et al., 1987) , it is not surprising that this antibody was not detected 8 weeks after infection. By using a lymphocyte proliferative test, no cell-mediated immune response was observed either, which indicates that there was complete or partial immune tolerance at the T cell level. Furthermore, no immune responses were induced by stimulation after active immunization with viral antigens in Freund's complete adjuvant. Therefore, this DHBV infection is a stable and reproducible immune tolerant animal model.
Immunization with SMAA has been shown to induce humoral and cytotoxic T cell immune response to simian virus 5 protein in a mouse model , and CD8 + cells could be responsible for virus clearance in vivo (Randall & Young, 1991) . In this paper an attempt was made using SMAA with polyclonal antiDHBs to mediate attachment of DHBsAg, for immunization of immune tolerant ducks. After three injections, clearance of viraemia (70%) and antigenaemia (50%) was shown in tolerant ducks. In some ducks, low titres of anti-DHBs were found. We have also tried to immunize congenitally infected ducks with SMAA; unfortunately, no changes in DHBV DNA or DHBsAg were seen (data not shown). In a separate study using a synthetic peptide cross-linked to a protein carrier to immunize tolerant ducks, only 50 % showed loss of serum DHBV DNA, whereas DHBsAg remained unchanged .
In this study, the SMAA approach seems effective in clearing viraemia and antigenaernia in a perinatally infected duck system. Although anti-DHBs was detected in only a few of the SMAA-immunized tolerant ducks, effective induction of immune responses in the other seroconverted tolerant ducks was still possible. Low titres of anti-DHBs produced could be complexed to the remnant DHBsAg in the blood circulation and thereby become undetectable. The sensitivity of the assays employed should also be considered. Although we failed to detect CMI against DHBsAg by the lymphocyte proliferative assay, lymphokine assays for monitoring CMI could give a positive result. In our previous study with HBV vaccinees, eight out of nine who responded with low titres of anti-HBs showed CMI towards HBsAg stimulation to produce interferon-gamma, whereas only one of nine was positive for CMI by the lymphocyte proliferative assay (Fei et al., 1989) .
Antibodies of the IgG class raised against HBsAg could potentiate the responses of human T helper cell clones to this antigen, and enhanced anti-HBs production of autologous B lymphocytes has been shown in vitro (Celis & Chang, 1984) . When HBsAg was complexed to the IgG class of anti-HBs in order to immunize mice, an increased anti-HBs response was seen (Celis et al., 1987) . SMAA could be readily phagocytosed by antigenpresenting cells due to the correct orientation of the bound antigen . In our immune tolerant ducks, we consider the successful reversion of immune tolerance by SMAA was mainly due to the antiDHBs produced (which has been identified as protective antibody). Free anti-DHBs as well as antibodies complexed with the antigen could modulate the T cell responses in vivo, and if the T helper cells were activated, they could potentiate antibody response and T cell cytotoxicity. In addition, the activation of complement and release of lymphokines (e.g. interferons) could also participate in clearance of the virus. Since T cells and their subsets have not been studied in ducks, the exact mechanisms await further studies.
The present study has implications for the control of chronic hepatitis B. Long-term follow-up studies and the use of other adjuvants are necessary to evaluate the significance of this approach.
